teplizumab fda approval

Keyword Analysis

Keyword	CPC	PCC	Volume	Score	Length of keyword
teplizumab fda approval	0.4	0.9	134	70	23
teplizumab	1.41	0.5	1960	53	10
fda	0.08	0.9	2689	29	3
approval	1.08	0.9	9698	30	8

Keyword	CPC	PCC	Volume	Score
teplizumab fda approval	1.32	0.2	3931	48
teplizumab fda approval 2022	0.87	0.9	5943	60
teplizumab fda approval date	1.79	0.5	6384	90
tocilizumab fda approval history	0.09	0.1	3652	34
teplizumab phase 3 trial	1.29	0.9	3725	26
tezepelumab fda approval date	1.16	0.1	8491	27
trastuzumab fda approval history	0.39	0.3	2273	33
atezolizumab fda approval date	0.66	0.8	1286	79
teclistamab fda approval date	1.26	0.8	7856	79
polatuzumab r/r fda approval	1.37	0.9	9956	93
national sales director teplizumab	1.72	0.6	694	94
palivizumab fda approval date	0.34	0.2	3064	43
atezolizumab fda approval history	1.84	0.6	6012	52
new drug approval fda 2022	0.36	0.6	9334	49
tocilizumab fda approved label	1.1	0.1	6625	6
fda approval list 2022	1.95	0.4	6575	61
tocilizumab fda approval covid	1.12	0.7	6391	60
eculizumab fda approval date	0.7	0.3	246	53
atezolizumab bevacizumab fda approval	0.24	0.8	9600	1
mirikizumab fda approval history	1.21	0.7	2118	26
pertuzumab fda approval history	0.41	0.7	2860	34
recent fda approvals 2022	2	0.5	3424	90
when was trastuzumab approved	1.34	0.1	5412	91
pembrolizumab fda label 2022	0.59	0.5	6331	84
teplizumab injection price in pakistan	0.86	0.7	1836	86
teplizumab route of administration	0.38	0.7	1203	44
tocilizumab price in usa	1.68	1	5559	19